AMBROSETTI, DAVIDE CARLO
AMBROSETTI, DAVIDE CARLO
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
Docenti di ruolo di IIa fascia
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling
2023 Gobbi G.; Grieco A.; Torricelli F.; Sauta E.; Santandrea G.; Zanetti E.; Fantini V.; Reggiani F.; Strocchi S.; Paci M.; Vohra M.; Saladi S.V.; Ambrosetti D.C.; Ciarrocchi A.; Sancisi V.
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
2021 Reggiani F.; Sauta E.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Damia G.; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V.
Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer
2021 Sauta E.; Reggiani F.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Strocchi S.; Paci M.; Damia G.; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V.
Genome-scale CRISPR/Cas9 screening identifies Hippo pathway as key determinant for susceptibility to BET inhibitors in lung cancer
2020 Gobbi, G; Donati, B; Do Valle, IF; Reggiani, F; Torricelli, F; Remondini, D; Castellani, G; Ambrosetti, DC; Ciarrocchi, A; Sancisi, V
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy
2020 Reggiani F.; Gobbi G.; Ciarrocchi A.; Ambrosetti D.C.; Sancisi V.
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells
2019 Gobbi G.; Donati B.; Do Valle I.F.; Reggiani F.; Torricelli F.; Remondini D.; Castellani G.; Ambrosetti D.C.; Ciarrocchi A.; Sancisi V.
Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2.
2015 Valentina, Sancisi; Greta, Gandolfi; Davide, Ambrosetti; Alessia, Ciarrocchi
The transcription factor Sox2 is required for osteoblast self-renewal.
2010 U. Basu-Roy; Ambrosetti D.; Favaro R.; Nicolis S.K.; Mansukhani A.; Basilico C.
Tollip Is a Mediator of Protein Sumoylation
2009 A. Ciarrocchi; R. D'Angelo; C. Cordiglieri; A. Rispoli; S. Santi; M. Riccio; S. Carone; A. L. Mancia; S. Paci; E. Cipollini; D. Ambrosetti; M. Melli
Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts
2008 Ambrosetti D; Holmes G; Mansukhani A; Basilico C.
Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum.
2005 Riccio M;Santi S;Dembic M;Di Giaimo R;Cipollini E;Costantino-Ceccarini E;Ambrosetti D;Maraldi NM;Melli M
Mechanisms underlying differential responses to FGF signaling.
2005 L. Dailey ; D. Ambrosetti; A. Mansukhani; C. Basilico
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
2005 A. MANSUKHANI; D. AMBROSETTI; G. HOLMES; L. CORNIVELLI; C. BASILICO.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling | Gobbi G.; Grieco A.; Torricelli F.; Sauta E.; Santandrea G.; Zanetti E.; Fantini V.; Reggiani F.;... Strocchi S.; Paci M.; Vohra M.; Saladi S.V.; Ambrosetti D.C.; Ciarrocchi A.; Sancisi V. | 2023-01-01 | CELL DEATH & DISEASE | - | 1.01 Articolo in rivista | s41419-023-06277-y.pdf; 41419_2023_6277_MOESM1_ESM.pdf; 41419_2023_6277_MOESM2_ESM.xlsx; 41419_2023_6277_MOESM3_ESM.xlsx; 41419_2023_6277_MOESM4_ESM.pdf |
| An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma | Reggiani F.; Sauta E.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Damia G....; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V. | 2021-01-01 | MOLECULAR CANCER | - | 1.01 Articolo in rivista | s12943-021-01357-z.pdf |
| Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer | Sauta E.; Reggiani F.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Strocch...i S.; Paci M.; Damia G.; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-03477.pdf |
| Genome-scale CRISPR/Cas9 screening identifies Hippo pathway as key determinant for susceptibility to BET inhibitors in lung cancer | Gobbi, G; Donati, B; Do Valle, IF; Reggiani, F; Torricelli, F; Remondini, D; Castellani, G; Ambro...setti, DC; Ciarrocchi, A; Sancisi, V | 2020-01-01 | MOLECULAR CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy | Reggiani F.; Gobbi G.; Ciarrocchi A.; Ambrosetti D.C.; Sancisi V. | 2020-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | - | 1.01 Articolo in rivista | Review YAP and TAZ_REV2_clean no numeri.docx |
| The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells | Gobbi G.; Donati B.; Do Valle I.F.; Reggiani F.; Torricelli F.; Remondini D.; Castellani G.; Ambr...osetti D.C.; Ciarrocchi A.; Sancisi V. | 2019-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2. | Valentina, Sancisi; Greta, Gandolfi; Davide, Ambrosetti; Alessia, Ciarrocchi | 2015-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| The transcription factor Sox2 is required for osteoblast self-renewal. | U. Basu-Roy; Ambrosetti D.; Favaro R.; Nicolis S.K.; Mansukhani A.; Basilico C. | 2010-01-01 | CELL DEATH AND DIFFERENTIATION | - | 1.01 Articolo in rivista | - |
| Tollip Is a Mediator of Protein Sumoylation | A. Ciarrocchi; R. D'Angelo; C. Cordiglieri; A. Rispoli; S. Santi; M. Riccio; S. Carone; A. L. Man...cia; S. Paci; E. Cipollini; D. Ambrosetti; M. Melli | 2009-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | - |
| Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts | Ambrosetti D; Holmes G; Mansukhani A; Basilico C. | 2008-01-01 | MOLECULAR AND CELLULAR BIOLOGY | - | 1.01 Articolo in rivista | - |
| Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum. | Riccio M;Santi S;Dembic M;Di Giaimo R;Cipollini E;Costantino-Ceccarini E;Ambrosetti D;Maraldi NM;...Melli M | 2005-01-01 | NEUROBIOLOGY OF DISEASE | - | 1.01 Articolo in rivista | - |
| Mechanisms underlying differential responses to FGF signaling. | L. Dailey ; D. Ambrosetti; A. Mansukhani; C. Basilico | 2005-01-01 | CYTOKINE & GROWTH FACTOR REVIEWS | - | 1.01 Articolo in rivista | - |
| Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. | A. MANSUKHANI; D. AMBROSETTI; G. HOLMES; L. CORNIVELLI; C. BASILICO. | 2005-01-01 | THE JOURNAL OF CELL BIOLOGY | - | 1.01 Articolo in rivista | - |